EMIS Health Implements Open Standards for Interoperability

EMISEMIS Health has become the first UK clinical systems provider to implement new open standards for interoperability in the NHS - enabling clinicians using its systems to securely share data with any other third party system across health and social care.

The announcement at an EMIS Health conference in Stratford-Upon-Avon (3 February 2016) will help the NHS to realise its vision of joined-up care for millions of patients. It follows the company's recent signing of techUK's Interoperability Charter.

From mid-February, the company will begin rolling out an update to its EMIS Web clinical system - used by almost 4,500 GP practices in England and Wales - that allows it to interoperate with any third party supplier who conforms to a published set of open application programme interfaces (APIs). These include the Fast Healthcare Interoperability resources (FHIR) standard and National terminology sets including SNOMED-CT and the NHS Data Dictionary.

In due course, clinicians, whatever IT system they use, with be able to securely share data with colleagues using any of EMIS Health's primary, community, secondary and pharmacy clinical systems.

This milestone puts in place a solid foundation for EMIS Health to rapidly evolve innovative interoperable services. Initially, third party systems will be able to securely obtain real-time primary care patient information, subject to tight information governance controls.

EMIS Group's Chief Medical Officer Dr Shaun O'Hanlon said: "For the last 13 years we have run a highly successful partner programme using our own API to enable integration with third party systems. We are now taking that commitment to a new level - using best practice standards developed by the wider healthcare IT industry as the basis on which we will open up access to our systems for any supplier within the NHS and social care, including NHS Trusts.

"This demonstrates our absolute dedication to freeing up the movement of vital patient information within the NHS to enable more joined-up and informed care. It also supports NHS England chief executive Simon Stevens' determination to make technology an enabler, not a barrier to new ways of organising clinical care."

The unimpeded, secure movement of data across the NHS is a major theme of an independent White Paper presented today by Mark Leaning, Visiting Professor at University College London and an innovator and entrepreneur in healthcare technology.

Related news articles:

About EMIS Health
EMIS Health is part of EMIS Group plc - the UK leader in connected healthcare software and services.

EMIS Health provides software and services to clinicians working across every major UK healthcare setting, including:

  • Primary Care - market leader with 54% share of the UK GP market; its systems hold 40 million cradle to grave patient records;
  • Community Children's and Mental Health Care - 9% and growing UK market share;
  • Secondary Care - 81% of NHS Acute Trusts use an EMIS Health system; its software holds 30 million patient records in A&E alone;
  • Community Pharmacy - the single most used integrated community pharmacy and retail system (36% UK market share);
  • Specialist Care - EMIS Health is the leading provider of software and services to support diabetic eye screening (82% English market share) and other ophthalmology and specialist services.

EMIS Health is an innovator in secure data-sharing to join up healthcare. It was the first in the UK to enable community pharmacists to access information from the GP patient record - supporting safer dispensing - and the first to integrate personal health data captured on wearable consumer devices with the GP patient record.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

Bayer Grants4Apps® Dealmaker Berlin 2017

Bayer Grants4Apps® is calling all mature teams, startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and Grants4Apps' experts...